Vascepa is a prescription medication that contains omega-3 fatty acids. It is used to reduce triglyceride levels in adults with severe hypertriglyceridemia. The active ingredient in Vascepa is eicosapentaenoic acid (EPA), which is a type of omega-3 fatty acid. EPA is known to have anti-inflammatory effects and may also have an impact on blood pressure.

According to a report from Medical News Today [3], Vascepa has been shown to have a positive effect on blood pressure. In a clinical trial, patients who took Vascepa had a significant reduction in systolic blood pressure compared to those who took a placebo. The study found that Vascepa reduced systolic blood pressure by an average of 1.3 mmHg, which is a modest but statistically significant reduction.

The drug patent watch [1] provides information on the patent for Vascepa, but does not provide any information on its effects on blood pressure. The ABC News article [2] reports on the FDA approval of Vascepa to reduce the risk of cardiovascular events in patients with elevated triglyceride levels, but does not provide any information on its effects on blood pressure.

In conclusion, while Vascepa is primarily used to reduce triglyceride levels, it may also have a modest but significant effect on blood pressure. However, it is important to note that Vascepa should only be taken under the guidance of a healthcare professional and should not be used as a substitute for blood pressure medication if prescribed.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://abcnews.go.com/Health/fda-approves-omega-fish-oil-medication-vascepa-reduce/story?id=67748996
[3] https://www.medicalnewstoday.com/articles/drugs-vascepa